datatrak international inc (DTRK) Key Developments
DATATRAK International, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014
Mar 11 15
DATATRAK International, Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company’s revenue was $2,815,068 compared to $2,848,013 a year ago. Loss from operations was $220,986 compared to income from operations of $183,209 a year ago. Net loss was $223,986 or $0.16 per diluted share compared to net income of $185,215 or $0.13 per diluted share a year ago.
For the year, the company’s revenues were $11,010,792 compared to $10,900,711 a year ago. Loss from operations was $1,280,221 compared to $873,377 a year ago. Net loss was $1,292,834 or $0.90 per basic and diluted share compared to $128,902 or $0.10 per basic and diluted share a year ago. The company's revenue increased 1% for the year ended December 31, 2014 compared to the year ended December 31, 2013 reflecting an evolving mix of revenue from shorter-term Trial-by-Trial agreements and an increasing number of longer-term enterprise agreements.
DATATRAK International, Inc. Presents at Noble Financial Capital Markets Eleventh Annual Investor Conference, Jan-19-2015 09:30 AM
Jan 6 15
DATATRAK International, Inc. Presents at Noble Financial Capital Markets Eleventh Annual Investor Conference, Jan-19-2015 09:30 AM. Venue: Club Med, Sandpiper Bay, Florida, United States. Speakers: Laurence P. Birch, Chairman of the Board, Chief Executive Officer and Chairman of Executive Committee.
DATATRAK International, Inc. Introduces Transformative eClinical Enterprise Applications
Dec 17 14
DATATRAK International, Inc. announced the introduction of unprecedented enterprise-wide eClinical tools to simplify clinical research
management. Amongst other improvements, three significant new applications have been added to the DATATRAK ONE®Unified Experience™. Cross-Study Managers fulfill the unique information needs of each research professional, whether reporting at an individual or cross-study level, with instant access to real-time enterprise-wide data. With flexible reporting capabilities across over 100 fields, users can tailor reports to address their precise requirements. The Cross-Study Manager is the latest addition to the full set of online Data Management tools available from DATATRAK. The Scheduler automates the delivery of the right information to the right person at the right time. Users can create a timeline of future actions, including the delivery of Standard and Ad-hoc reports, Exports and Sub-set Exports and Imports at the study or enterprise-wide level. With File Versioning, trial teams can improve the quality of data with instant access to current and previous versions of files across all studies on the DATATRAK ONE®Unified Experience™. Users facilitate collaboration in the cloud with a single location to view study documentation.
DATATRAK International, Inc. Presents at LD Micro Conference, Dec-04-2014 07:30 AM
Dec 1 14
DATATRAK International, Inc. Presents at LD Micro Conference, Dec-04-2014 07:30 AM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, California, United States.
DATATRAK International, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014
Nov 12 14
DATATRAK International, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenue of $2,694,547 against $3,015,987 a year ago. Loss from operations was $396,831 against income from operations of $134,179 a year ago. Net loss was $400,181 or $0.28 per diluted share against net income of $133,954 or $0.09 per diluted share a year ago. Revenue decreased in the quarter due to timing impacts and the effect of deal flow and cancellations in previous quarters.
For the nine months, the company reported revenue of $8.20 million increased 2% compared to revenue of $8.05 million a year ago.